148
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Engineering of solidified glyburide nanocrystals for tablet formulation via loading of carriers: downstream processing, characterization, and bioavailability

, &
Pages 1893-1906 | Published online: 13 Mar 2019

References

  • FuQLiBZhangDComparative studies of the in vitro dissolution and in vivo pharmacokinetics for different formulation strategies (solid dispersion, micronization, and nanocrystals) for poorly water-soluble drugs: a case study for lacidipineColloids Surf B: Biointerf2015132Supplement C171176
  • JinnoJKamadaNMiyakeMEffect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogsJ Control Release20061111–2566416410029
  • SalazarJGhanemAMüllerRHMöschwitzerJPNanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approachesEur J Pharm Biopharm2012811829022233547
  • JunghannsJUMüllerRHNanocrystal technology, drug delivery and clinical applicationsInt J Nanomed200833295310
  • AssadpourEJafariSMA systematic review on nanoencapsulation of food bioactive ingredients and nutraceuticals by various nanocarriersCrit Rev Food Sci Nutr201863123
  • GadadareRMandpeLPokharkarVUltra rapidly dissolving repaglinide nanosized crystals prepared via bottom-up and top-down approach: influence of food on pharmacokinetics behaviorAAPS PharmSciTech201516478779925549790
  • RomeroGBBryschWKeckCMMüllerRHNanocapsule formation by nanocrystalsJafariSMNanoencapsulation Technologies for the Food and Nutraceutical IndustriesCambridge, MAAcademic Press2017165186
  • Raghava SrivalliKMMishraBDrug nanocrystals: a way toward scale-upSaudi Pharm J201624438640427330370
  • MüllerRHGohlaSKeckCMState of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular deliveryEur J Pharm Biopharm20117811921266197
  • MüllerRHShegokarRKeckCM20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applicationsCurr Drug Discov Technol20118320722721291409
  • PawarVKSinghYMeherJGGuptaSChourasiaMKEngineered nanocrystal technology: in-vivo fate, targeting and applications in drug deliveryJ Control Release2014183Supplement C516624667572
  • WuLZhangJWatanabeWPhysical and chemical stability of drug nanoparticlesAdv Drug Deliv Rev201163645646921315781
  • D’AddioSMPrud’hommeRKControlling drug nanoparticle formation by rapid precipitationAdv Drug Deliv Rev201163641742621565233
  • RabinowBENanosuspensions in drug deliveryNat Rev Drug Discov20043978579615340388
  • ArpagausCCollenbergARüttiDAssadpourEJafariSMNano spray drying for encapsulation of pharmaceuticalsInt J Pharm20185461–219421429778825
  • CalKSollohubKSpray drying technique. I: hardware and process parametersJ Pharm Sci201099257558619774644
  • WaltersRHBhatnagarBTchessalovSIzutsuKITsumotoKOhtakeSNext generation drying technologies for pharmaceutical applicationsJ Pharm Sci201410392673269524916125
  • HeWLuYQiJChenLYinLWuWFormulating food protein-stabilized indomethacin nanosuspensions into pellets by fluid-bed coating technology: physical characterization, redispersibility, and dissolutionInt J Nanomed2013831193128
  • TuomelaALaaksonenTLaruJSolid formulations by a nanocrystal approach: critical process parameters regarding scale-ability of nano-crystals for tableting applicationsInt J Pharm20154851–2778625746735
  • YuLLiCLeYChenJ-FZouHStabilized amorphous glibenclamide nanoparticles by high-gravity techniqueMater Chem Phys20111301–2361366
  • GuanJHanJZhangDIncreased dissolution rate and oral bioavailability of hydrophobic drug glyburide tablets produced using supercritical CO2 silica dispersion technologyEur J Pharm Biopharm201486337638224184803
  • WeiHLöbenbergRBiorelevant dissolution media as a predictive tool for glyburide a class II drugEur J Pharm Sci2006291455216815694
  • LiuHShangKLiuWImproved oral bioavailability of glyburide by a self-nanoemulsifying drug delivery systemJ Microencapsul201431327728324533514
  • BetageriGMakarlaKREnhancement of dissolution of glyburide by solid dispersion and lyophilization techniquesInt J Pharm19951261–2155160
  • SavolainenJJärvinenKTaipaleHJarhoPLoftssonTJärvinenTCo-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage formsPharm Res19981511169617019833990
  • NnamaniPOAttamaAAIbezimECAdikwuMUSRMS142-based solid lipid microparticles: application in oral delivery of glibenclamide to diabetic ratsEur J Pharm Biopharm2010761687420554020
  • ShahSRParikhRHChavdaJRShethNRApplication of Plackett– Burman screening design for preparing glibenclamide nanoparticles for dissolution enhancementPowder Technol2013235Supplement C405411
  • GonçalvesLMMaestrelliFdi Cesare MannelliLGhelardiniCAlmeidaAJMuraPDevelopment of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamideEur J Pharm Biopharm2016102Supplement C415026925503
  • AliHSMHanafyAFGlibenclamide nanocrystals in a biodegradable chitosan patch for transdermal delivery: engineering, formulation, and evaluationJ Pharm Sci2017106140241027866687
  • ZhangXGuanJNiRLiLCMaoSPreparation and solidification of redispersible nanosuspensionsJ Pharm Sci201410372166217624840928
  • YuePFWanJWangYD-alpha-tocopherol acid polyethylene glycol 1000 succinate, an effective stabilizer during solidification transformation of baicalin nanosuspensionsInt J Pharm20134431–227928723291447
  • OsamuraTTakeuchiYOnoderaRFormulation design of granules prepared by wet granulation method using a multi-functional single-punch tablet press to avoid tableting failuresAsian J Pharm Sci2018132113119
  • JaipakdeeNLimpongsaESripanidkulchaiBOPiyachaturawatPPreparation of Curcuma comosa tablets using liquisolid techniques: in vitro and in vivo evaluationInt J Pharm20185531–215716830316793
  • SalazarJMüllerRHMöschwitzerJPApplication of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tabletsEur J Pharm Sci201349456557723587645
  • SallamNMSanadRAKharshoumRMZineldinMADevelopment of salbutamol sulphate fast disintegrating sublingual tablets with enhanced bioavailability and improved clinical efficacy for potential treatment of asthmaJ Drug Deliv Sci Technol2017417889
  • YangWWangYFuQThe role of particle size of glyburide crystals in improving its oral absorptionDrug Deliv Transl Res20177342843828364197
  • LucioDIracheJMFontMMartínez-OhárrizMCSupramolecular structure of glibenclamide and β-cyclodextrins complexesInt J Pharm20175301–237738628779983
  • ElbahwyIAIbrahimHMIsmaelHRKasemAAEnhancing bioavailability and controlling the release of glibenclamide from optimized solid lipid nanoparticlesJ Drug Deliv Sci Technol2017387889
  • MoghimiSMHunterACPoloxamers and poloxamines in nanoparticle engineering and experimental medicineTrends Biotechnol2000181041242010998507
  • LiuPViitalaTKartal-HodzicAInteraction studies between indomethacin nanocrystals and PEO/PPO copolymer stabilizersPharm Res201532262863925145336
  • MorakulBSuksiriworapongJLeanpolchareanchaiJJunyaprasertVBPrecipitation-lyophilization-homogenization (PLH) for preparation of clarithromycin nanocrystals: influencing factors on physicochemical properties and stabilityInt J Pharm2013457118719624076396
  • LucioDMartínez-OhárrizMCJarasGOptimization and evaluation of zein nanoparticles to improve the oral delivery of glibenclamide in vivo study using C. elegansEur J Pharm Biopharm201712110411228986295
  • LeeHJLeeHGKwonYBThe role of lactose carrier on the powder behavior and aerodynamic performance of bosentan microparticles for dry powder inhalationEur J Pharm Sci201811727928929510172
  • EmamiJKazemaliMRDesign and in vitro evaluation of a novel controlled onset extended-release delivery system of metoprolol tartrateRes Pharm Sci2016111819227051436
  • LaiSLGuoJYPetrovaVRamanathGAllenLHSize-dependent melting properties of small tin particles: nanocalorimetric measurementsPhys Rev Lett19967719910210061781
  • MoolchandaniVAugsburgerLLGuptaAKhanMLangridgeJHoagSWCharacterization and selection of suitable grades of lactose as functional fillers for capsule filling: Part 1Drug Dev Ind Pharm20154191452146325212639
  • FuQLiBZhangDComparative studies of the in vitro dissolution and in vivo pharmacokinetics for different formulation strategies (solid dispersion, micronization, and nanocrystals) for poorly water-soluble drugs: a case study for lacidipineColloids Surf B Biointerfaces201513217117626047880
  • MöschwitzerJPMüllerRHFactors influencing the release kinetics of drug nanocrystal-loaded pellet formulationsDrug Dev Ind Pharm201339576276922803784
  • HengDOgawaKCutlerDJPure drug nanoparticles in tablets: what are the dissolution limitations?J Nanopart Res201012517431754
  • HeCYinLTangCYinCSize-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugsBiomaterials201233338569857822906606
  • BaekIHKimJSHaESDissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl celluloseInt J Biol Macromol201467535724631786
  • MuSLiMGuoMSpironolactone nanocrystals for oral administration: different pharmacokinetic performances induced by stabilizersColloids Surf B Biointerfaces2016147738027490456
  • JiangTHanNZhaoBXieYWangSEnhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sono-precipitationDrug Dev Ind Pharm201238101230123922229827